MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,663,000 | -78.1% | 27,224 | -71.9% | 0.16% | -79.1% |
| Q4 2020 | $21,257,000 | -25.7% | 96,783 | -43.9% | 0.74% | -41.7% |
| Q3 2020 | $28,623,000 | +45.4% | 172,377 | 0.0% | 1.27% | +36.6% |
| Q2 2020 | $19,680,000 | +21.0% | 172,377 | -18.5% | 0.93% | -8.9% |
| Q1 2020 | $16,265,000 | -33.1% | 211,597 | +12.2% | 1.02% | +2.7% |
| Q4 2019 | $24,310,000 | +143.6% | 188,651 | +47.3% | 0.99% | +124.7% |
| Q3 2019 | $9,978,000 | – | 128,071 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |